125 related articles for article (PubMed ID: 9333149)
1. Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection.
Aukrust P; Hestdal K; Lien E; Bjerkeli V; Nordøy I; Espevik T; Müller F; Frøland SS
J Infect Dis; 1997 Oct; 176(4):913-23. PubMed ID: 9333149
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.
Hestdal K; Aukrust P; Müller F; Lien E; Bjerkeli V; Espevik T; Frøland SS
Blood; 1997 Oct; 90(7):2670-9. PubMed ID: 9326234
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure.
Aukrust P; Müller F; Lien E; Nordoy I; Liabakk NB; Kvale D; Espevik T; Froland SS
J Infect Dis; 1999 Jan; 179(1):74-82. PubMed ID: 9841825
[TBL] [Abstract][Full Text] [Related]
4. Increased soluble tumor necrosis factor receptor expression and release by human immunodeficiency virus type 1 infection.
Kalinkovich A; Geleziunas R; Kemper O; Belenki D; Wallach D; Wainberg MA; Bentwich Z
J Interferon Cytokine Res; 1995 Sep; 15(9):749-57. PubMed ID: 8536102
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection.
Zangerle R; Gallati H; Sarcletti M; Wachter H; Fuchs D
Immunol Lett; 1994 Jul; 41(2-3):229-34. PubMed ID: 8002043
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.
Rizzardi GP; Barcellini W; Tambussi G; Lillo F; Malnati M; Perrin L; Lazzarin A
AIDS; 1996 Nov; 10(13):F45-50. PubMed ID: 8931778
[TBL] [Abstract][Full Text] [Related]
7. HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells.
Chiao C; Bader T; Stenger JE; Baldwin W; Brady J; Barrett JC
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1125-32. PubMed ID: 11522182
[TBL] [Abstract][Full Text] [Related]
8. Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells.
Vey E; Burger D; Dayer JM
Eur J Immunol; 1996 Oct; 26(10):2404-9. PubMed ID: 8898953
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea.
Nokta M; Rossero R; Loesch K; Pollard RB
AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1633-8. PubMed ID: 9430255
[TBL] [Abstract][Full Text] [Related]
10. Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection.
Arnold R; König B; Galatti H; Werchau H; König W
Immunology; 1995 Jul; 85(3):364-72. PubMed ID: 7558123
[TBL] [Abstract][Full Text] [Related]
11. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis.
Riordan SM; Skinner N; Nagree A; McCallum H; McIver CJ; Kurtovic J; Hamilton JA; Bengmark S; Williams R; Visvanathan K
Hepatology; 2003 May; 37(5):1154-64. PubMed ID: 12717397
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
[TBL] [Abstract][Full Text] [Related]
14. Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients.
Siedlar M; Strach M; Bukowska-Strakova K; Lenart M; Szaflarska A; Węglarczyk K; Rutkowska M; Baj-Krzyworzeka M; Pituch-Noworolska A; Kowalczyk D; Grodzicki T; Ziegler-Heitbrock L; Zembala M
Clin Immunol; 2011 May; 139(2):122-32. PubMed ID: 21300572
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals.
Vermeulen JN; Prins JM; Bunnik E; Hack CE; Jurriaans S; Miedema F; Lange JM; Schuitemaker H
AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1348-53. PubMed ID: 18184076
[TBL] [Abstract][Full Text] [Related]
16. Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system.
Aukrust P; Müller F; Svenson M; Nordøy I; Bendtzen K; Frøland SS
Clin Exp Immunol; 1999 Jan; 115(1):136-43. PubMed ID: 9933433
[TBL] [Abstract][Full Text] [Related]
17. Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000).
Reading C; Dowding C; Schramm B; Garsd A; Onizuka-Handa N; Stickney D; Frincke J
Clin Microbiol Infect; 2006 Nov; 12(11):1082-8. PubMed ID: 17002607
[TBL] [Abstract][Full Text] [Related]
18. Effect of 1 alpha-hydroxyvitamin D3 treatment on production of tumor necrosis factor-alpha by peripheral blood mononuclear cells and on serum concentrations of soluble tumor necrosis factor receptors in hemodialysis patients.
Haran N; Gurwicz S; Gallati H; Shalita B; Bar-Khayim Y
Nephron; 1994; 66(3):262-6. PubMed ID: 8190177
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumour necrosis factor alpha & soluble TNF receptors in patients with Guillain-Barre syndrome.
Radhakrishnan VV; Sumi MG; Reuben S; Mathai A; Nair MD
Indian J Med Res; 2003 May; 117():216-20. PubMed ID: 14609050
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
